← FDA Drug Approvals (Drugs@FDA)

LEVOCETIRIZINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2019-04-01

Drug application

FDA Application #

ANDA210914

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOCETIRIZINE HYDROCHLORIDE

Generic name

LEVOCETIRIZINE DIHYDROCHLORIDE

Active ingredients

LEVOCETIRIZINE DIHYDROCHLORIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2019-04-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown